International Normalized Ratio fluctuation with warfarin-fluorouracil therapy [1]

American Journal of Health-System Pharmacy

Volumn 59, Issue 9, 2002, Pages 875-

  Carabino, Jana ^a   Wang, Fei ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C9; FLUOROURACIL; FOLINIC ACID; VITAMIN K GROUP; WARFARIN;

CANCER CHEMOTHERAPY; COLON CANCER; DEEP VEIN THROMBOSIS; DRUG ABSORPTION; DRUG METABOLISM; ENZYME SYNTHESIS; HUMAN; INTERNATIONAL STANDARD UNIT; LETTER; PRIORITY JOURNAL;

EID: 0036570285     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.9.875     Document Type: Letter

References (6)

1. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin
2. An adverse interaction between warfarin and 5-fluorouracil: A case report and review of the literature
3. Possible drug interaction between warfarin and combination of levamisole and fluorouracil
4. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil
5. Possible interactions between warfarin and 5-fluorouracil
6. Warfarin-5-FU interaction - A consecutive case series